









Mercados
/
Ações
/
nasdaq-gkos
/

Glaukos Corp

GKOS

86.380USD

+0.220+0.26%

Horário de mercado （ET）Cotações atrasadas em 15 min

4.95BValor de mercado

PerdaP/L TTM



Glaukos Corp

86.380

+0.220+0.26%

Visão Geral Empresa Serviços Financeiros

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. It develops novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders and retinal disease. Its product candidates include Micro-Invasive Glaucoma Surgery products that involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma and procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time. Its products include transdermal pharmaceuticals that are applied to the eyelid and designed to treat glaucoma, dry eye, presbyopia and other ocular surface diseases and disorders and micro-invasive, bio-erodible sustained release drug delivery implants to improve the vision of patients.

Informações da empresa

Código da empresaGKOS

Nome da EmpresaGlaukos Corp

Data de listagemJun 25, 2015

CEOMr. Thomas William Burns

Número de funcionários995

Tipo de títulosOrdinary Share

Fim do ano fiscalJun 25

Endereço1 Glaukos Way

CidadeALISO VIEJO

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal92656

Telefone19493679600

Sitehttps://www.glaukos.com

Código da empresaGKOS

Data de listagemJun 25, 2015

CEOMr. Thomas William Burns

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.50M

-0.34%

Mr. David F. Hoffmeister

Independent Director

69.52K

+56.16%

Mr. Mark J. Foley

Lead Independent Director

56.36K

+3.89%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.23K

+4.47%

Dr. Tomas Navratil

Chief Development Officer

38.02K

-2.55%

Mr. Marc A. Stapley

Independent Director

36.18K

+6.19%

Dr. Leana S. Wen, M.D.

Independent Director

Dr. Gilbert H. (Gil) Kliman, M.D.

Independent Director

Ms. Denice M. Torres, J.D.

Independent Director

Mr. Joseph E. Gilliam

President, Chief Operating Officer

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.50M

-0.34%

Mr. David F. Hoffmeister

Independent Director

69.52K

+56.16%

Mr. Mark J. Foley

Lead Independent Director

56.36K

+3.89%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.23K

+4.47%

Dr. Tomas Navratil

Chief Development Officer

38.02K

-2.55%

Mr. Marc A. Stapley

Independent Director

36.18K

+6.19%

Detalhamento da receita

Moeda: USDAtualizado em: dom, 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por EmpresaUSD

Nome

Receita

Proporção

Glaucoma

88.14M

82.63%

Corneal Health

18.53M

17.37%

Por RegiãoUSD

Nome

Receita

Proporção

United States

75.07M

70.38%

International

31.59M

29.62%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Glaucoma

88.14M

82.63%

Corneal Health

18.53M

17.37%

Distribuição de ações

Atualizado em: dom, 3 de ago

Investidores

Tipos de investidores

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

13.35%

The Vanguard Group, Inc.

10.40%

Fidelity Management & Research Company LLC

9.73%

Wellington Management Company, LLP

4.00%

State Street Global Advisors (US)

3.47%

Other

59.06%

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

13.35%

The Vanguard Group, Inc.

10.40%

Fidelity Management & Research Company LLC

9.73%

Wellington Management Company, LLP

4.00%

State Street Global Advisors (US)

3.47%

Other

59.06%

Tipos de investidores

Investidores

Proporção

Investment Advisor

53.97%

Investment Advisor/Hedge Fund

34.40%

Hedge Fund

8.12%

Individual Investor

3.33%

Research Firm

1.86%

Pension Fund

1.85%

Sovereign Wealth Fund

1.10%

Bank and Trust

1.05%

Venture Capital

0.34%

Participação acionária institucional

Atualizado em: ter, 1 de jul

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q2

634

60.63M

105.91%

-341.50K

2025Q1

643

60.20M

105.40%

-1.30M

2024Q4

610

59.75M

105.65%

+533.86K

2024Q3

567

57.47M

104.31%

-894.95K

2024Q2

545

56.86M

103.79%

-713.22K

2024Q1

509

54.47M

110.12%

-1.91M

2023Q4

480

53.71M

109.34%

-1.79M

2023Q3

475

52.90M

108.58%

-1.85M

2023Q2

486

51.69M

106.83%

-2.99M

2023Q1

490

50.54M

105.57%

-3.20M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

BlackRock Institutional Trust Company, N.A.

7.64M

13.38%

-218.59K

-2.78%

Mar 31, 2025

The Vanguard Group, Inc.

5.95M

10.42%

-9.86K

-0.17%

Mar 31, 2025

Fidelity Management & Research Company LLC

5.57M

9.74%

+417.67K

+8.11%

Mar 31, 2025

Wellington Management Company, LLP

2.29M

4.01%

+131.25K

+6.08%

Mar 31, 2025

State Street Global Advisors (US)

1.98M

3.47%

-79.01K

-3.83%

Mar 31, 2025

Burns (Thomas William)

1.50M

2.62%

-5.16K

-0.34%

May 27, 2025

AllianceBernstein L.P.

1.28M

2.24%

+461.39K

+56.53%

Mar 31, 2025

PRIMECAP Management Company

1.22M

2.13%

+4.15K

+0.34%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.22M

2.13%

+17.85K

+1.49%

Mar 31, 2025

Brown Capital Management, LLC

1.19M

2.09%

-155.27K

-11.52%

Mar 31, 2025

Ver Mais

ETFs Relacionados

Atualizado em: sáb, 2 de ago

Nome

Proporção

Invesco S&P SmallCap Health Care ETF

4.22%

Harbor Health Care ETF

2.42%

SPDR S&P Health Care Equipment ETF

1.9%

Invesco S&P SmallCap Momentum ETF

1.66%

ROBO Global Healthcare Technology & Innovation ETF

1.59%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.86%

SPDR S&P 600 Small Cap Growth ETF

0.86%

iShares S&P Small-Cap 600 Growth ETF

0.81%

iShares U.S. Medical Devices ETF

0.67%

SPDR S&P SmallCap 600 ESG ETF

0.62%

Ver Mais

Invesco S&P SmallCap Health Care ETF

Proporção4.22%

Harbor Health Care ETF

Proporção2.42%

SPDR S&P Health Care Equipment ETF

Proporção1.9%

Invesco S&P SmallCap Momentum ETF

Proporção1.66%

ROBO Global Healthcare Technology & Innovation ETF

Proporção1.59%

Vanguard S&P Small-Cap 600 Growth Index Fund

Proporção0.86%

SPDR S&P 600 Small Cap Growth ETF

Proporção0.86%

iShares S&P Small-Cap 600 Growth ETF

Proporção0.81%

iShares U.S. Medical Devices ETF

Proporção0.67%

SPDR S&P SmallCap 600 ESG ETF

Proporção0.62%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

